BRIEF published on 11/01/2024 at 14:00, 1 year 10 months ago Novacyt: Update on liquidity contract and voting rights Common Shares Voting Rights Liquidity Contract INVEST SECURITIES Novacyt
BRIEF published on 11/01/2024 at 13:57, 1 year 10 months ago Novacyt Updates on Liquidity Agreement and Voting Rights Liquidity Agreement INVEST SECURITIES Total Voting Rights French Law Novacyt Shares
PRESS RELEASE published on 11/01/2024 at 13:52, 1 year 10 months ago Liquidity Agreement and Total Voting Rights Novacyt provides liquidity agreement update and total voting rights information, with Invest Securities purchasing and selling ordinary shares. Company divided into clinical, instrumentation, and research use segments Ordinary Shares Liquidity Agreement Total Voting Rights Novacyt Clinical Diagnostics
BRIEF published on 10/31/2024 at 10:28, 1 year 10 months ago Dr. Ian Gilham Joins Novacyt as Non-Executive Director Life Sciences Board Appointment Non-Executive Director Novacyt Dr. Ian Gilham
BRIEF published on 10/31/2024 at 10:25, 1 year 10 months ago Appointment of Dr Ian Gilham to the Board of Directors of Novacyt Board Of Directors Life Sciences Appointment Novacyt Ian Gilham
PRESS RELEASE published on 10/31/2024 at 10:23, 1 year 10 months ago Directorate Change Novacyt appoints Dr Ian Gilham as Non-Executive Director, bringing expertise in life sciences companies to strengthen the Board Life Sciences Non-Executive Director Novacyt Dr Ian Gilham AIM-listed
BRIEF published on 10/17/2024 at 11:47, 1 year 10 months ago IVDR Certification for Yourgene® Cystic Fibrosis Test by Novacyt Screening Novacyt IVDR Cystic Fibrosis Yourgene
BRIEF published on 10/10/2024 at 12:28, 1 year 11 months ago Novacyt closes its IT-IS International subsidiary EBITDA Closing Novacyt IT-IS International PCR Market
BRIEF published on 10/10/2024 at 12:27, 1 year 11 months ago Novacyt Closes IT-IS International Subsidiary Amid Market Saturation Financial Impact Intellectual Property Novacyt PCR Market IT-IS Closure
PRESS RELEASE published on 10/10/2024 at 12:22, 1 year 11 months ago Closure of IT-IS International Novacyt announces closure of IT-IS International subsidiary to improve EBITDA. Retains IP for ongoing dispute with Roche Diagnostics. Focus on future growth and cost reduction EBITDA Closure Novacyt IT-IS International IP Dispute
Published on 09/16/2026 at 23:45, 5 hours 3 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 7 hours 18 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 11 hours 53 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 13 hours 48 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 14 hours 48 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/17/2026 at 04:25, 22 minutes ago Zhou Jianjun from Huawei: Building a Grid-Interactive AIDC Solution to Maximize Tokens Per Watt
Published on 09/16/2026 at 23:45, 5 hours 2 minutes ago WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT
Published on 09/16/2026 at 22:33, 6 hours 14 minutes ago EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”
Published on 09/16/2026 at 21:15, 7 hours 32 minutes ago Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals
Published on 09/16/2026 at 20:27, 8 hours 20 minutes ago EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million
Published on 09/16/2026 at 17:45, 11 hours 3 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 21 hours 48 minutes ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 10 hours ago Report on the Combined General Meeting of the 10th of September 2026
